Nexgenrx Inc.(NXG-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.440
Day High0.445
Open:0.440
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
ACCESS Newswire
NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth
ACCESS Newswire
Nexgenrx Announces Declaration of Divdend
Newsfile
Upcoming Meeting Dates - April 6, 2026
ACCESS Newswire
NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth
ACCESS Newswire
NexgenRx Announces Declaration of Divdends
ACCESS Newswire
NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth
ACCESS Newswire
NexgenRx Announces Declaration of Dividend
ACCESS Newswire
NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA
AI-generated - The Globe and Mail
NexgenRx: Top 25 Undervalued Dividend Stocks on TSX-V (NXG)
ACCESS Newswire
NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
ACCESS Newswire
NexgenRx Announces Declaration of Divdend
ACCESS Newswire
NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA
ACCESS Newswire
NexgenRx Announces Third Quarter Results and Declaration of Divdend
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
AI-generated - The Globe and Mail
NexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)
ACCESS Newswire
NexgenRx Announces Director Re-Appointment
AI-generated - The Globe and Mail
NexgenRx: Top 25 Undervalued Dividend Stocks on TSX-V (NXG)
ACCESS Newswire
NexgenRx Announces Share Issuances Under Consulting Agreement

Profile

NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. The various solutions offered by the company include: NexSys, a fully integrated rules-based adjudication platform for real-time processing of drug, dental, and extended health benefit claims; NexAdmin, which enables sponsors to take complete control of benefit plan administration; and NexPSPAssist, a service that helps Patient Support Programs (PSP) to optimize their deliverables to their manufacturer clients. The company has only one operating segment - benefits administration services.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.